Goldstein A M, Goldin L R, Dracopoli N C, Clark W H, Tucker M A
Genetic Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20892-7372, USA.
Am J Hum Genet. 1996 May;58(5):1050-6.
Previous linkage analyses of 19 cutaneous malignant melanoma/dysplastic nevi (CMM/DN) kindreds showed significant evidence of linkage and heterogeneity to both chromosomes 1p and 9p. Five kindreds also showed evidence of linkage (Z>0.7) to both regions. To further examine these findings, we conducted two-trait-locus, two-marker-locus linkage analysis. We examined one homogeneity and one heterogeneity single-locus model (SL-Hom and SL-Het), and two-locus (2L) models: an epistatic model (Ep), in which CMM was treated as a genuine 2L disease, and a heterogeneity model (Het), in which CMM could result from disease alleles at either locus. Both loci were modeled as autosomal dominant. The LOD scores for CMM alone were highest using the SL-Het model (Z = 8.48, theta = .0). There was much stronger evidence of linkage to chromosome 9p than to 1p for CMM alone; the LOD scores were approximately two times greater on 9p than on 1p. The change in LOD scores from an evaluation of CMM alone to CMM/DN suggested that a chromosome 1p locus (or loci) contributed to both CMM and CMM/DN, whereas a 9p locus contributed more to CMM alone. For both 2L models, the LOD scores from 1p were greater for CMM/DN than for CMM alone (Ep: Z=4.63 vs. 3.83; Het: 4.94 vs. 3.80, respectively). In contrast, for 9p, the LOD scores were substantially lower with CMM/DN than with CMM alone (Ep: 4.64 vs. 7.06; Het: 5.38 vs. 7.99, respectively). After conditioning on linkage to the other locus, only the 9p locus consistently showed significant evidence for linkage to CMM alone. Thus, the application of 2L models may be useful to help unravel the complexities of familial melanoma.
先前对19个皮肤恶性黑色素瘤/发育异常痣(CMM/DN)家系进行的连锁分析显示,有显著证据表明1号染色体和9号染色体均存在连锁和异质性。5个家系在这两个区域也显示出连锁证据(Z>0.7)。为了进一步研究这些发现,我们进行了双性状位点、双标记位点连锁分析。我们研究了一个同质性单基因座模型和一个异质性单基因座模型(SL-Hom和SL-Het),以及双基因座(2L)模型:一个上位性模型(Ep),其中CMM被视为真正的双基因座疾病;另一个是异质性模型(Het),其中CMM可能由任一基因座的疾病等位基因导致。两个基因座均被建模为常染色体显性遗传。单独针对CMM的对数优势分数在使用SL-Het模型时最高(Z = 8.48,θ = 0)。单独针对CMM,与1号染色体相比,与9号染色体的连锁证据要强得多;9号染色体上的对数优势分数约为1号染色体上的两倍。从单独评估CMM到评估CMM/DN时对数优势分数的变化表明,1号染色体上的一个或多个基因座对CMM和CMM/DN均有影响,而9号染色体上的一个基因座对单独的CMM影响更大。对于两个双基因座模型,CMM/DN在1号染色体上的对数优势分数均高于单独的CMM(Ep:Z = 4.63对3.83;Het:分别为4.94对3.80)。相比之下,对于9号染色体,CMM/DN的对数优势分数显著低于单独的CMM(Ep:4.64对7.0 + 6;Het:5.38对7.99)。在以与另一个基因座的连锁为条件后,只有9号染色体基因座始终显示出与单独CMM连锁的显著证据。因此,双基因座模型的应用可能有助于揭示家族性黑色素瘤的复杂性。